Radioligand therapy (RLT) has helped change what’s possible in prostate cancer treatment, but Novartis continues to work on the next wave of innovations to bring new options to patients.

Phil Gotwals talks about his vision for the future of business development for research.

Functional genomics study reveals a potential approach for tackling glioblastoma, pancreatic cancer and other tumors.

Novartis has been at the forefront of advances in how blood cancers and serious blood disorders are treated, helping patients live their best lives.

How two years in a Novartis lab changed Johnny Castillo’s life.

Novartis has launched a comprehensive research program to help find the right combinations of therapies for the right patients.

Novartis and Broad Institute researchers explore how gut bacteria contribute to health and disease, beginning with type 1 diabetes.

Zebrafish imaging sheds light on human neurological conditions.